ARQT · ISSUER CIK 1787306
Arcutis Biotherapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 6 Arcutis Biotherapeutics, Inc. insiders reported $0.00 of open-market purchases and $2.3M of sales on SEC Form 4.
↗6 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 8 of 12 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$2.3MInsider selling
−$2.3MNet open-market
Oct 28, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 202616:20 | Oct 23, 2026 | ARQT | Director | A · GrantLate 5d | — | +2,819 | 2,819 | New | — | ||
| Oct 19, 202616:49 | Oct 15, 2026 | ARQT | Director | S · Sell10b5-1 | $26.93 | −4,728 | 35,207 | -12% | −$127K | ||
| Oct 19, 202616:49 | Oct 15, 2026 | ARQT | Director | M · Exercise10b5-1 | $7.93 | +4,094 | 39,935 | +11% | $32K | ||
| Sep 18, 202616:17 | Sep 16, 2026 | ARQT | See Remarks | S · Sell10b5-1 | $25.00 | −3,674 | 112,508 | -3% | −$92K | ||
| Sep 17, 202616:06 | Sep 15, 2026 | ARQT | Director | S · Sell10b5-1 | $24.18 | −4,730 | 35,841 | -12% | −$114K | ||
| Sep 17, 202616:06 | Sep 15, 2026 | ARQT | Director | M · Exercise10b5-1 | $7.93 | +4,096 | 40,571 | +11% | $32K | ||
| Sep 10, 202619:24 | Sep 8, 2026 | ARQT | See Remarks | S · Sell10b5-1 | $25.03 | −9,989 | 116,182 | -8% | −$250K | ||
| Aug 28, 202617:40 | Aug 27, 2026 | ARQT | Director | S · Sell | $25.03 | −38,200 | 23,526 | -62% | −$956K | ||
| Aug 28, 202617:40 | Aug 27, 2026 | ARQT | Director | M · Exercise | $8.30 | +38,200 | 50,578 | +309% | $317K | ||
| Aug 24, 202616:19 | Aug 20, 2026 | ARQT | Director | S · Sell | $26.04 | −1,072 | 23,526 | -4% | −$28K | ||
| Aug 24, 202616:19 | Aug 20, 2026 | ARQT | Director | M · Exercise | $7.51 | +1,072 | 24,598 | +5% | $8K | ||
| Aug 21, 202616:08 | Aug 19, 2026 | ARQT | See Remarks | S · Sell | $27.00 | −1,697 | 117,592 | -1% | −$46K | ||
| Aug 19, 202616:57 | Aug 17, 2026 | ARQT | Director | S · Sell10b5-1 | $26.18 | −4,730 | 36,475 | -11% | −$124K | ||
| Aug 19, 202616:57 | Aug 17, 2026 | ARQT | Director | M · Exercise10b5-1 | $7.93 | +4,096 | 41,205 | +11% | $32K | ||
| Aug 13, 202620:06 | Aug 12, 2026from Aug 11, 2026 | ARQT | See Remarks | S · Sell | $26.33 | −15,000 | 119,289 | -11% | −$395K | ||
| Aug 13, 202620:06 | Aug 12, 2026from Aug 11, 2026 | ARQT | See Remarks | M · Exercise | $3.64 | +15,000 | 125,989 | +14% | $55K | ||
| Aug 5, 202621:42 | Aug 3, 2026 | ARQT | See Remarks | S · Sell10b5-1 | $26.12 | −955 | 119,289 | -1% | −$25K | ||
| Aug 5, 202621:42 | Aug 3, 2026 | ARQT | See Remarks | S · Sell10b5-1 | $26.12 | −1,230 | 126,171 | -1% | −$32K | ||
| Aug 5, 202621:42 | Aug 3, 2026 | ARQT | See Remarks, Director | S · Sell10b5-1 | $26.12 | −4,375 | 717,203 | -1% | −$114K |